Statement Of Cash Flows [Abstract]

Biotage - Filing #689619

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities	—	5,000,000 SEK	—	3,000,000 SEK	—
Interest received, classified as operating activities	—	2,000,000 SEK	—	0 SEK	—
Cash flows from (used in) operating activities	—	341,000,000 SEK	—	353,000,000 SEK	—
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities	—	12,000,000 SEK	—	282,000,000 SEK	—
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities	—	2,000,000 SEK	—	2,000,000 SEK	—
Purchase of property, plant and equipment, classified as investing activities	—	35,000,000 SEK	—	23,000,000 SEK	—
Purchase of intangible assets, classified as investing activities	—	35,000,000 SEK	—	3 3 SEK	—
Proceeds from sales of other long-term assets, classified as investing activities	—	– SEK	—	– SEK	—
Cash flows from (used in) investing activities	—	84,000,000 SEK	—	3 41 SEK	—
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities	—	150,000,000 SEK	—	15 0 SEK	—
Repayments of borrowings, classified as financing activities	—	180,000,000 SEK	—	13 4 SEK	—
Cash flows from (used in) financing activities	—	133,000,000 SEK	—	82,000,000 SEK	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	—	124,000,000 SEK	—	69,000,000 SEK	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	7,000,000 SEK	—	9,000,000 SEK	—
Cash and cash equivalents	4 41 SEK	—	311,000,000 SEK	—	371,000,000 SEK